ANDA 40231, held by Pharm Assoc. Chlorpromazine Hydrochloride.
As of Nov 16, 2026, ANDA 40231 (Chlorpromazine Hydrochloride), held by Pharm Assoc, was first approved by FDA on Dec 30, 1999, with 0 approved supplements and 0 published complete response letters.
| Date | Submission | Status | Documents |
|---|---|---|---|
| Dec 30, 1999 | Original application | Approved |
| Product | Active ingredient | Marketing |
|---|---|---|
| Chlorpromazine Hydrochloride30MG/ML ยท concentrate;oral | Chlorpromazine Hydrochloride | Discontinued |
Approvals, supplements, products and documents come from FDA's Drugs@FDA data files, refreshed daily; Drugs@FDA lists approved applications only. Complete response letters are FDA's published letters. Drugs@FDA and FDA complete response letters